Mrv1909 11151922072D 17 18 0 0 0 0 999 V2000 -0.2690 0.3255 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.1434 1.0400 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.2690 1.7544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.9684 1.0400 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3809 1.7544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3809 0.3255 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.2059 0.3255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.9684 -0.3889 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3809 -1.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9684 -1.8179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1434 -0.3889 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7539 -0.3419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5385 -0.0869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2059 -0.5718 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -1.5385 0.7380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7539 0.9929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7539 1.8179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 11 1 6 0 0 0 1 12 1 0 0 0 0 1 16 1 0 0 0 0 2 3 1 6 0 0 0 2 4 1 0 0 0 0 4 5 1 1 0 0 0 4 6 1 0 0 0 0 6 7 1 6 0 0 0 6 8 1 0 0 0 0 8 9 1 1 0 0 0 8 11 1 0 0 0 0 9 10 1 0 0 0 0 13 12 1 0 0 0 0 13 14 2 0 0 0 0 13 15 1 0 0 0 0 16 15 1 0 0 0 0 16 17 2 0 0 0 0 M END > DB02964 > drugbank > OC[C@H]1O[C@@]2(NC(=S)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O > InChI=1S/C8H12N2O6S/c11-1-2-3(12)4(13)5(14)8(16-2)6(15)9-7(17)10-8/h2-5,11-14H,1H2,(H2,9,10,15,17)/t2-,3-,4+,5-,8+/m1/s1 > OEWLGQKSTDZKFN-WWHASAIZSA-N > C8H12N2O6S > 264.256 > 264.041606816 > 6 > 29 > 23.295591600905624 > 1 > 6 > 0 > 0 > (5S,7R,8S,9S,10R)-8,9,10-trihydroxy-7-(hydroxymethyl)-2-sulfanylidene-6-oxa-1,3-diazaspiro[4.5]decan-4-one > -2.4356276273333335 > 0 > 2 > 0 > 12.351761708036282 > 9.212404013927967 > -2.9808774238600906 > 131.28 > 56.95689999999999 > 1 > 0 > [(2R)-2-(4-aminobutanamido)-3-{[(4-methoxyphenyl)methyl]sulfanyl}propanamido]acetic acid > 0 > DB02964 > EXPT01597 > experimental > 8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one $$$$